Scientific Reports · 2017 · 65 citations · 45 references
Life SciencesCell BiologyOncologyCancer GeneticsGenome EditingMolecular OncologyCancer Cell SignalingCancer Stem CellsCrispr-cas SystemsMalignant NeoplasmsMetabolic ReprogrammingMetabolic Reprogramming In CancerCancer Gene EditingCeramide MetabolismCrispr-cas9 Genome EditingCrispr-cas9 KnockoutCrispr-cas9 Knockout ModelsCrispr-cas9 Mediated Knock-inCysteine HydrolasesTumor Initiating Cells
Acid ceramidase (AC) is a lysosomal cysteine hydrolase that catalyzes the conversion of ceramide into fatty acid and sphingosine. This reaction lowers intracellular ceramide levels and concomitantly generates sphingosine used for sphingosine-1-phosphate (S1P) production. Since increases in ceramide and consequent decreases of S1P reduce proliferation of various cancers, AC might offer a new target for anti-tumor therapy. Here we used CrispR-Cas9-mediated gene editing to delete the gene encoding for AC, ASAH1, in human A375 melanoma cells. ASAH1-null clones show significantly greater accumulation of long-chain saturated ceramides that are substrate for AC. As seen with administration of exogenous ceramide, AC ablation blocks cell cycle progression and accelerates senescence. Importantly, ASAH1-null cells also lose the ability to form cancer-initiating cells and to undergo self-renewal, which is suggestive of a key role for AC in maintaining malignancy and self-renewal of invasive melanoma cells. The results suggest that AC inhibitors might find therapeutic use as adjuvant therapy for advanced melanoma.
45
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran, Patrick D. Hsu, Jason Wright et al. · Nature Protocols · 2013 · 11.7K citations · Full text
Programmed Cell Death Induced by Ceramide
Lina M. Obeid, Corinne M. Linardic, Linda A. Karolak et al. · Science · 1993 · 1.8K citations
Senescence‐associated β‐galactosidase is lysosomal β‐galactosidase
Bo Yun Lee, Jung A Han, Jun Sub Im et al. · Aging Cell · 2006 · 1.4K citations · Full text